已收盘 09-19 16:00:00 美东时间
+0.164
+0.40%
Earnings Call Insights: Dyadic International, Inc. (DYAI) Q2 2025 Management View Joseph P. Hazelton, President & COO, stated Dyadic has shifted from a platform-focused R&D company to a commercially-d...
08-14 07:52
IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after six months in both dose groups, although more
06-05 23:48
The REX NVDA Growth & Income ETF is a new single-stock covered call fund aiming to ride NVDA's growth potential and profit from volatility.
05-29 20:55
2025年第一季度中国清洁能源建设景气指数(CEPI)为113.43,同比上升0.22点,环比下降3.03点,CEPI仍处于较景气区间。
05-15 15:13
Valneva's chikungunya vaccine Ixchiq receives Brazil approval, enabling expanded trials and access across Latin America and endemic regions.
04-15 02:28
Saint Herblain (France), April 14, 2025 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its
04-14 23:48
转自:经济日报新闻客户端 日前,中国电力建设企业协会发布2024年第四季度中国清洁能源建设景气指数(CEPI)。数据显示,2024年第四季度中国清洁能源...
02-12 14:42
Orexo (OTCQX:ORXOY) has entered into a collaboration with Abera Bioscience ('Abera'), a platform and vaccine developer, to broaden the use of its powder-based drug delivery technology AmorphOX®. As a ...
2024-12-17 16:55